International Consensus Calls for Rapid MRI Scans in Prostate Cancer Screening
International experts have issued a consensus statement advocating for the use of quick, targeted MRI scans in prostate cancer screening to minimise overdiagnosis and avoid unnecessary biopsies. This recommendation, developed by researchers from Imperial College London, proposes that men aged 50 to 70, or from 45 for black men, undergo rapid MRI scans lasting under 15 minutes, following initial PSA tests.
Standardising Protocols for Future Screening Programmes
The guidelines aim to standardise protocols for future prostate cancer screening initiatives and will inform the ongoing Transform trial by Prostate Cancer UK, which is investigating promising screening techniques. This move comes as the UK National Screening Committee (UKNSC) previously advised against routine population-wide prostate cancer screening using PSA tests, citing concerns about overdiagnosis and potential harm to patients.
Risk-Based Approach Could Reduce MRI Referrals by 60%
In a related development, a separate study presented at the same medical congress demonstrated that a risk-based approach to prostate cancer screening could significantly reduce MRI referrals by up to 60 per cent. This finding underscores the potential benefits of targeted screening methods in improving efficiency and patient outcomes.
Key Recommendations:
- Rapid MRI scans under 15 minutes for men aged 50-70.
- Earlier screening from age 45 for black men due to higher risk.
- Pre-screening with PSA tests to identify candidates for MRI.
- Focus on reducing overdiagnosis and unnecessary invasive procedures.
These expert recommendations highlight a shift towards more precise and less invasive screening methods, potentially transforming prostate cancer detection and treatment protocols in the coming years.
